StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Mustang Bio's price to book ratio was 0.4× on Nov 11, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.3× to 94.4×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×+0.0
2025Dec 31, 20250.4×−17.0
2024Apr 30, 202417.3×+14.6
2023Dec 29, 20232.7×+2.0
2022Dec 30, 20220.8×−0.7
2021Dec 31, 20211.5×−2.0
2020Dec 31, 20203.5×+0.5
2019Dec 31, 20193.0×+1.0
2018Dec 31, 20182.0×−3.4
2017Dec 29, 20175.5×–

More Mustang Bio figures

See a number that looks wrong?